36 related articles for article (PubMed ID: 2858546)
1. Development of Test Programs for the Biorelevant Characterization of Esophageal-Applied Dosage Forms.
Brokmann F; Feindt F; Weitschies W; Rosenbaum C
Polymers (Basel); 2023 Aug; 15(16):. PubMed ID: 37631487
[TBL] [Abstract][Full Text] [Related]
2. Dysphagia for medication in Parkinson's disease.
Labeit B; Berkovich E; Claus I; Roderigo M; Schwake AL; Izgelov D; Mimrod D; Ahring S; Oelenberg S; Muhle P; Zentsch V; Wenninger F; Suntrup-Krueger S; Dziewas R; Warnecke T
NPJ Parkinsons Dis; 2022 Nov; 8(1):156. PubMed ID: 36371409
[TBL] [Abstract][Full Text] [Related]
3. An Investigation into the Relationship between Xanthan Gum Film Coating Materials and Predicted Oro-Esophageal Gliding Performance for Solid Oral Dosage Forms.
Drumond N; Stegemann S
Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33419280
[TBL] [Abstract][Full Text] [Related]
4. Better Medicines for Older Patients: Considerations between Patient Characteristics and Solid Oral Dosage Form Designs to Improve Swallowing Experience.
Drumond N; Stegemann S
Pharmaceutics; 2020 Dec; 13(1):. PubMed ID: 33379258
[TBL] [Abstract][Full Text] [Related]
5. Patient-Centric Medicine Design: Key Characteristics of Oral Solid Dosage Forms that Improve Adherence and Acceptance in Older People.
Shariff Z; Kirby D; Missaghi S; Rajabi-Siahboomi A; Maidment I
Pharmaceutics; 2020 Sep; 12(10):. PubMed ID: 32977445
[TBL] [Abstract][Full Text] [Related]
6. Patient-centred pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations.
Liu F; Ranmal S; Batchelor HK; Orlu-Gul M; Ernest TB; Thomas IW; Flanagan T; Tuleu C
Drugs; 2014 Oct; 74(16):1871-1889. PubMed ID: 25274536
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic evaluation of rofecoxib : comparison of tablet and suspension formulations.
Schwartz JI; Larson PJ; Porras AG; Viswanathan-Aiyer KJ; Agrawal NG; Lasseter KC; Mazenko RS; Merschman SA; Gertz BJ
Clin Drug Investig; 2003; 23(8):503-9. PubMed ID: 17535062
[TBL] [Abstract][Full Text] [Related]
8. A case of oesophageal ulcer developed after taking homeopathic pill in a young woman.
Corleto VD; D'Alonzo L; Zykaj E; Carnuccio A; Chiesara F; Pagnini C; Di Somma S; Delle Fave G
World J Gastroenterol; 2007 Apr; 13(14):2132-4. PubMed ID: 17465462
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of capsule swallowing by healthy young men and capsule transit time from the mouth to the stomach.
Chisaka H; Matsushima Y; Wada F; Saeki S; Hachisuka K
Dysphagia; 2006 Oct; 21(4):275-9. PubMed ID: 17216387
[TBL] [Abstract][Full Text] [Related]
10. Bioadhesive dosage forms for esophageal drug delivery.
Batchelor H
Pharm Res; 2005 Feb; 22(2):175-81. PubMed ID: 15783063
[TBL] [Abstract][Full Text] [Related]
11. What the gastroenterologist should know about the gastrointestinal safety profiles of bisphosphonates.
Graham DY
Dig Dis Sci; 2002 Aug; 47(8):1665-78. PubMed ID: 12184516
[TBL] [Abstract][Full Text] [Related]
12. Foreign body entrapment in the esophagus of healthy subjects--a manometric and scintigraphic study.
Stein HJ; Schwizer W; DeMeester TR; Albertucci M; Bonavina L; Spires-Williams KJ
Dysphagia; 1992; 7(4):220-5. PubMed ID: 1424835
[TBL] [Abstract][Full Text] [Related]
13. The effect of size and shape of tablets on their esophageal transit.
Channer KS; Virjee JP
J Clin Pharmacol; 1986 Feb; 26(2):141-6. PubMed ID: 3950057
[TBL] [Abstract][Full Text] [Related]
14. Oesophageal transit of six commonly used tablets and capsules.
Hey H; Jørgensen F; Sørensen K; Hasselbalch H; Wamberg T
Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1717-9. PubMed ID: 6816343
[TBL] [Abstract][Full Text] [Related]
15. Effect of left atrial size on the oesophageal transit of capsules.
Channer KS; Bell J; Virjee JP
Br Heart J; 1984 Aug; 52(2):223-7. PubMed ID: 6234911
[TBL] [Abstract][Full Text] [Related]
16. Crushing tablets or opening capsules: many uncertainties, some established dangers.
Prescrire Int; 2014 Sep; 23(152):209-11, 213-4. PubMed ID: 25325120
[TBL] [Abstract][Full Text] [Related]
17. Drug-induced oesophageal disorders: pathogenesis, incidence, prevention and management.
Jaspersen D
Drug Saf; 2000 Mar; 22(3):237-49. PubMed ID: 10738847
[TBL] [Abstract][Full Text] [Related]
18. The effect of formulation on oesophageal transit.
Channer KS; Virjee JP
J Pharm Pharmacol; 1985 Feb; 37(2):126-9. PubMed ID: 2858546
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
